Global Pneumococcal Polysaccharide Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 28-Sep-2018
No. of pages: 120

Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age.

Scope of the Report:

This report focuses on the Pneumococcal Polysaccharide Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23.

The worldwide market for Pneumococcal Polysaccharide Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Merck & Co., Inc.

- Pfizer Inc.

- Glaxosmithkline Plc.

- Sanofi Pasteur

- China National Biotec Group

- Astellas Pharma Inc

- Serum Institute of India Pvt. Ltd

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Single Dose Vial

- Pre-Filled Syringe

Market Segment by Applications, can be divided into

- Children (2-10 Age)

- Adult (10-64 Age)

- Geriatric (More Than 65 Age)

There are 15 Chapters to deeply display the global Pneumococcal Polysaccharide Vaccine market.

Chapter 1, to describe Pneumococcal Polysaccharide Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Pneumococcal Polysaccharide Vaccine, with sales, revenue, and price of Pneumococcal Polysaccharide Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Pneumococcal Polysaccharide Vaccine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Pneumococcal Polysaccharide Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Pneumococcal Polysaccharide Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Pneumococcal Polysaccharide Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Pneumococcal Polysaccharide Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Single Dose Vial
1.2.2 Pre-Filled Syringe
1.3 Market Analysis by Applications
1.3.1 Children (2-10 Age)
1.3.2 Adult (10-64 Age)
1.3.3 Geriatric (More Than 65 Age)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck & Co., Inc.
2.1.1 Business Overview
2.1.2 Pneumococcal Polysaccharide Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer Inc.
2.2.1 Business Overview
2.2.2 Pneumococcal Polysaccharide Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Glaxosmithkline Plc.
2.3.1 Business Overview
2.3.2 Pneumococcal Polysaccharide Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi Pasteur
2.4.1 Business Overview
2.4.2 Pneumococcal Polysaccharide Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 China National Biotec Group
2.5.1 Business Overview
2.5.2 Pneumococcal Polysaccharide Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 China National Biotec Group Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Astellas Pharma Inc
2.6.1 Business Overview
2.6.2 Pneumococcal Polysaccharide Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Serum Institute of India Pvt. Ltd
2.7.1 Business Overview
2.7.2 Pneumococcal Polysaccharide Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Pneumococcal Polysaccharide Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Pneumococcal Polysaccharide Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2017
3.3.2 Top 6 Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Pneumococcal Polysaccharide Vaccine Market Analysis by Regions
4.1 Global Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Pneumococcal Polysaccharide Vaccine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Regions (2013-2018)
4.2 North America Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
4.3 Europe Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
4.5 South America Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
5 North America Pneumococcal Polysaccharide Vaccine by Countries
5.1 North America Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Pneumococcal Polysaccharide Vaccine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Countries (2013-2018)
5.2 United States Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
5.3 Canada Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
5.4 Mexico Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
6 Europe Pneumococcal Polysaccharide Vaccine by Countries
6.1 Europe Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Pneumococcal Polysaccharide Vaccine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
6.3 UK Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
6.4 France Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
6.5 Russia Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
6.6 Italy Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Pneumococcal Polysaccharide Vaccine by Countries
7.1 Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Countries (2013-2018)
7.2 China Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
7.3 Japan Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
7.4 Korea Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
7.5 India Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
8 South America Pneumococcal Polysaccharide Vaccine by Countries
8.1 South America Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Pneumococcal Polysaccharide Vaccine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
8.3 Argentina Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
8.4 Colombia Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Pneumococcal Polysaccharide Vaccine by Countries
9.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
9.3 UAE Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
9.4 Egypt Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
9.5 Nigeria Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
9.6 South Africa Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
10 Global Pneumococcal Polysaccharide Vaccine Market Segment by Type
10.1 Global Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Single Dose Vial Sales Growth and Price
10.2.1 Global Single Dose Vial Sales Growth (2013-2018)
10.2.2 Global Single Dose Vial Price (2013-2018)
10.3 Pre-Filled Syringe Sales Growth and Price
10.3.1 Global Pre-Filled Syringe Sales Growth (2013-2018)
10.3.2 Global Pre-Filled Syringe Price (2013-2018)
11 Global Pneumococcal Polysaccharide Vaccine Market Segment by Application
11.1 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2013-2018)
11.2 Children (2-10 Age) Sales Growth (2013-2018)
11.3 Adult (10-64 Age) Sales Growth (2013-2018)
11.4 Geriatric (More Than 65 Age) Sales Growth (2013-2018)
12 Pneumococcal Polysaccharide Vaccine Market Forecast (2018-2023)
12.1 Global Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Pneumococcal Polysaccharide Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Pneumococcal Polysaccharide Vaccine Market Forecast (2018-2023)
12.2.2 Europe Pneumococcal Polysaccharide Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Forecast (2018-2023)
12.2.4 South America Pneumococcal Polysaccharide Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Forecast (2018-2023)
12.3 Pneumococcal Polysaccharide Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Pneumococcal Polysaccharide Vaccine Market Share Forecast by Type (2018-2023)
12.4 Pneumococcal Polysaccharide Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Pneumococcal Polysaccharide Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Pneumococcal Polysaccharide Vaccine Picture
Table Product Specifications of Pneumococcal Polysaccharide Vaccine
Figure Global Sales Market Share of Pneumococcal Polysaccharide Vaccine by Types in 2017
Table Pneumococcal Polysaccharide Vaccine Types for Major Manufacturers
Figure Single Dose Vial Picture
Figure Pre-Filled Syringe Picture
Figure Pneumococcal Polysaccharide Vaccine Sales Market Share by Applications in 2017
Figure Children (2-10 Age) Picture
Figure Adult (10-64 Age) Picture
Figure Geriatric (More Than 65 Age) Picture
Figure United States Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure France Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure UK Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure China Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure India Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2013-2023)
Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Type and Applications
Table Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc. Pneumococcal Polysaccharide Vaccine Type and Applications
Table Pfizer Inc. Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Glaxosmithkline Plc. Basic Information, Manufacturing Base and Competitors
Table Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Type and Applications
Table Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Type and Applications
Table Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table China National Biotec Group Basic Information, Manufacturing Base and Competitors
Table China National Biotec Group Pneumococcal Polysaccharide Vaccine Type and Applications
Table China National Biotec Group Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Pharma Inc Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Type and Applications
Table Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Serum Institute of India Pvt. Ltd Basic Information, Manufacturing Base and Competitors
Table Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Type and Applications
Table Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Pneumococcal Polysaccharide Vaccine Sales by Manufacturer (2016-2017)
Figure Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturer in 2016
Figure Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturer in 2017
Table Global Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2016-2017)
Figure Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturer in 2016
Figure Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturer in 2017
Figure Top 3 Pneumococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Pneumococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Global Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Global Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2013-2018)
Table Global Pneumococcal Polysaccharide Vaccine Sales by Regions (2013-2018)
Table Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions (2013-2018)
Table Global Pneumococcal Polysaccharide Vaccine Revenue by Regions (2013-2018)
Figure Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2013
Figure Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2017
Figure North America Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Europe Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure South America Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure North America Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2013-2018)
Table North America Pneumococcal Polysaccharide Vaccine Sales by Countries (2013-2018)
Table North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2013-2018)
Figure North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2013
Figure North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2017
Table North America Pneumococcal Polysaccharide Vaccine Revenue by Countries (2013-2018)
Table North America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2013-2018)
Figure North America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2013
Figure North America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2017
Figure United States Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Canada Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Mexico Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Europe Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2013-2018)
Table Europe Pneumococcal Polysaccharide Vaccine Sales by Countries (2013-2018)
Table Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2013-2018)
Table Europe Pneumococcal Polysaccharide Vaccine Revenue by Countries (2013-2018)
Figure Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2016
Figure Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2017
Figure Germany Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure UK Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure France Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Russia Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Italy Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales by Countries (2013-2018)
Table Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries 2017
Table Asia-Pacific Pneumococcal Polysaccharide Vaccine Revenue by Countries (2013-2018)
Figure Asia-Pacific Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries 2017
Figure China Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Japan Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Korea Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure India Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Southeast Asia Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure South America Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2013-2018)
Table South America Pneumococcal Polysaccharide Vaccine Sales by Countries (2013-2018)
Table South America Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2013-2018)
Figure South America Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2017
Table South America Pneumococcal Polysaccharide Vaccine Revenue by Countries (2013-2018)
Table South America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2013-2018)
Figure South America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2017
Figure Brazil Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Argentina Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Colombia Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Countries (2013-2018)
Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2017
Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Countries (2013-2018)
Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2013
Figure Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2017
Figure Saudi Arabia Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure UAE Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Egypt Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure Nigeria Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Figure South Africa Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
Table Global Pneumococcal Polysaccharide Vaccine Sales by Type (2013-2018)
Table Global Pneumococcal Polysaccharide Vaccine Sales Share by Type (2013-2018)
Table Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2013-2018)
Table Global Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2013-2018)
Figure Global Single Dose Vial Sales Growth (2013-2018)
Figure Global Single Dose Vial Price (2013-2018)
Figure Global Pre-Filled Syringe Sales Growth (2013-2018)
Figure Global Pre-Filled Syringe Price (2013-2018)
Table Global Pneumococcal Polysaccharide Vaccine Sales by Application (2013-2018)
Table Global Pneumococcal Polysaccharide Vaccine Sales Share by Application (2013-2018)
Figure Global Adult (10-64 Age) Sales Growth (2013-2018)
Figure Global Geriatric (More Than 65 Age) Sales Growth (2013-2018)
Figure Global Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate (2018-2023)
Table Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Regions (2018-2023)
Table Global Pneumococcal Polysaccharide Vaccine Market Share Forecast by Regions (2018-2023)
Figure North America Sales Pneumococcal Polysaccharide Vaccine Market Forecast (2018-2023)
Figure Europe Sales Pneumococcal Polysaccharide Vaccine Market Forecast (2018-2023)
Figure Asia-Pacific Sales Pneumococcal Polysaccharide Vaccine Market Forecast (2018-2023)
Figure South America Sales Pneumococcal Polysaccharide Vaccine Market Forecast (2018-2023)
Figure Middle East and Africa Sales Pneumococcal Polysaccharide Vaccine Market Forecast (2018-2023)
Table Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2018-2023)
Table Global Pneumococcal Polysaccharide Vaccine Market Share Forecast by Type (2018-2023)
Table Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2018-2023)
Table Global Pneumococcal Polysaccharide Vaccine Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Meningococcal Conjugate Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 16-Jun-2019        Price: US 3000 Onwards        Pages: 148
    Meningococcal Conjugate Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Meningococcal Conjugate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Meningococcal Conjugate manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Ch......
  • Global Pneumococcal Polysaccharide Vaccine Market Insights, Forecast to 2025
    Published: 14-Jun-2019        Price: US 3900 Onwards        Pages: 112
    Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age. The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23.  The global Pneumococcal Po......
  • Influenza Vaccine Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)
    Published: 13-Jun-2019        Price: US 2280 Onwards        Pages: 58
    According to 99Strategy, the Global Influenza Vaccine Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Influenza Vaccine market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving......
  • Global Encephalitis Vaccine Market Insights, Forecast to 2025
    Published: 10-Jun-2019        Price: US 3900 Onwards        Pages: 113
    Encephalitis virus is a mosquito-borne Flavivirus and is transmitted via an enzootic cycle from mosquitoes to amplifying vertebrate hosts such as pigs and wading birds. It can easily be prevented using vaccines. It is the most common cause of encephalitis in Asia-Pacific. Encephalitis virus can easily be transmitted to humans through an infected mosquito bite and occurs primarily in rural agricultural areas. The global Encephalitis Vaccine market is valued at xx million US$ in 2018......
  • Meningococcal Vaccines Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)
    Published: 07-Jun-2019        Price: US 2280 Onwards        Pages: 59
    According to 99Strategy, the Global Meningococcal Vaccines Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Meningococcal Vaccines market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the facto......
  • Global H1N1 Vaccines Market Insights, Forecast to 2025
    Published: 31-May-2019        Price: US 3900 Onwards        Pages: 114
    A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The global H1N1 vaccination market is anticipated to boost in the focus period due to the rising cases of swine flu. Additionally, the rising geriatric population increases the risk of respiratory tract diseases, and immune deficient diseases, thus increasing the risk factor ......
  • Global Meningococcal Conjugate Market Size, Status and Forecast 2019-2025
    Published: 29-May-2019        Price: US 3900 Onwards        Pages: 90
    Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease. In 2018, the global Meningococcal Conjugate market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.......
  • Global Influenza Vaccine Market Research Report 2012-2024
    Published: 27-May-2019        Price: US 1960 Onwards        Pages: 79
    Summary The global Influenza Vaccine market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as fo......
  • Global Influenza Vaccine Market Insights, Forecast to 2025
    Published: 17-May-2019        Price: US 3900 Onwards        Pages: 120
    Influenza vaccines are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. The European Centre for Disease Prevention and Control also recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five year......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs